Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort Academic Article uri icon

Overview

MeSH Major

  • Culture Techniques
  • Organoids
  • Prostatic Neoplasms

abstract

  • ClinicalTrials.gov identifier NCT01171898.

publication date

  • January 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5568792

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2016.04.023

PubMed ID

  • 27160947

Additional Document Info